Cargando…

COVID-19 and the heart: what we have learnt so far

Since the outbreak of COVID-19 or coronavirus disease caused by severe acute respiratory syndrome coronavirus 2 from Wuhan, China, the cardiology fraternity’s interest has been drawn towards the pandemic with a high case fatality rate of 10.5% and 6% in patients with heart disease and hypertension,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaha, Kunal Bikram, Manandhar, Dhiraj Narayan, Cho, Jung Rae, Adhikari, Ashok, K C, Man Bahadur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016902/ https://www.ncbi.nlm.nih.gov/pubmed/32943474 http://dx.doi.org/10.1136/postgradmedj-2020-138284

Ejemplares similares

Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022)

What have we learnt so far from COVID-19?
por: Doherty, Peter C.
Publicado: (2021)

Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Implementation of the Nagoya Protocol in Livestock Sector: What Have We Learnt So Far?
por: Martyniuk, Elzbieta, et al.
Publicado: (2021)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Proximal tubular dysfunction in patients with COVID-19: what have we learnt so far?
por: Braun, Fabian, et al.
Publicado: (2020)

Alcohol consumption during COVID-19 pandemic: What have we learnt so far?
por: Nogueira, V., et al.
Publicado: (2021)

Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far?
por: Handy, Richard D., et al.
Publicado: (2012)

What we have learnt (so far) about deliberative dialogue for evidence-based policymaking in West Africa
por: Ridde, Valéry, et al.
Publicado: (2017)

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
por: Lazarevic, Ivana, et al.
Publicado: (2021)

COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020)

The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

OMICs in Cariology and Endodontology – what have we learned so far?
por: Zaura, Egija
Publicado: (2017)

Circadian Clocks in Fish—What Have We Learned so far?
por: Frøland Steindal, Inga A., et al.
Publicado: (2019)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
por: Barcellini, Amelia, et al.
Publicado: (2022)

ECMO Retrieval Program: What Have We Learned So Far
por: Krasivskyi, Ihor, et al.
Publicado: (2023)

Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?
por: Corsetti, Maura, et al.
Publicado: (2019)

What we know so far
Publicado: (2021)

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far
por: Jäckel, Claudia, et al.
Publicado: (2019)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)

How Does SARS-CoV-2 Affect Our Eyes—What Have We Learnt So Far about the Ophthalmic Manifestations of COVID-19?
por: Baj, Jacek, et al.
Publicado: (2022)

Defining transposition: What have we learnt?
por: Roderick, Max E., et al.
Publicado: (2021)

What have we learnt from Covid?
por: Salter, Mark Steven
Publicado: (2021)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Neural synchrony within the motor system: what have we learned so far?
por: van Wijk, Bernadette C. M., et al.
Publicado: (2012)

NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
por: Raut, Nirmal V, et al.
Publicado: (2010)

Combining inclusive and exclusive data analyses-what have we learned so far?
por: Kittel, E W
Publicado: (1973)

Theory: Historical perspective and what have we learned from the Higgs so far
por: Ellis, Jonathan R.
Publicado: (2022)

Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far
por: Pacitti, Dario, et al.
Publicado: (2018)

The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far?
por: Walsh, Mary Norine, et al.
Publicado: (2020)

Gene Therapy in Rare Respiratory Diseases: What Have We Learned So Far?
por: Bañuls, Lucía, et al.
Publicado: (2020)

More on the MORE Life Experience Model: What We Have Learned (So Far)
por: Glück, Judith, et al.
Publicado: (2018)

Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
por: Fukui, Hiroshi
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mft7hkq1eqof3joks37k2p3m93